Mirati Therapeutics Eulerpool News

Mirati Therapeutics Stock News

Mirati Therapeutics is being monitored by journalists and investors worldwide. We gather the latest Mirati Therapeutics news here.

• March 11 ·

  Nasdaq
  Pre-market Movers: EXN, ONE, TLYS, IMVT, LAZY…
• March 4 ·

  CNBC
  Disney+ to launch cheaper ad-supported tier later this year
• February 28 ·

  Thefly.com
  Mirati Therapeutics reports Q4 EPS ($3.72), consensus ($3.00)
• February 17 ·

  GuruFocus
  Suvretta Capital Management, Llc Buys Microsoft Corp, Monster Beverage Corp, Hilton Worldwide Holdings Inc, Sells Twilio Inc, Mastercard Inc, Adobe Inc
• February 16 ·

  Yahoo
  What You Need To Know About The Mirati Therapeutics, Inc. (NASDAQ:MRTX) Analyst Downgrade Today
• February 15 ·

  Yahoo
  U.S. Food and Drug Administration (FDA) Accepts Mirati Therapeutics' New Drug Application for Adagrasib as Treatment of Previously Treated KRASG12C-Mutated Non-Small Cell Lung Cancer
• February 10 ·

  CNBC
  'Incredible beat' in Disney's park business wows Wall Street analysts
• February 9 ·

  GuruFocus
  Stenahm Asset Managment Ltd Buys Canadian Pacific Railway, Match Group Inc, PayPal Holdings Inc, Sells Booking Holdings Inc, Taiwan Semiconductor Manufacturing Co, Visa Inc
• January 1 ·

  DowJones
  How the election can affect your investments